OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB. (March 2023)

• Record Type: Journal Article
• Authors: Sacco, R.; Ciruolo, M.; Paolillo, R.; Ramai, D.; Tortora, R.; Di, Costanzo G.G.; Burlone, M.; Pirisi, M.; Federico, P.; Daniele, B.; Silletta, M.; Gallo, P.; Cocuzza, C.; Russello, M.; Cabibbo, G.; Cesario, S.; Masi, G.; Marzi, L.; Mega, A.; Granito, A.; Pieri, G.; Giannini, E.; Gadaleta-Caldarola, G.; Dadduzio, V.; Giordano, G.; Giacomelli, L.; Papa, S.; Renzulli, M.; Maida, M.; Ghidini, M.; Facciorusso, A.;
• Is Part Of: Digestive and liver disease. Volume 55(2023)Supplement 2
• Page Start: S119
• Page End: S120
• Publication Date: 2023-03
• Subjects: Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/S1590-8658(23)00311-0
• Languages: English
• ISSNs: 1590-8658